Literature DB >> 15330806

Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking.

P J Craig1, A U Wells, S Doffman, D Rassl, T V Colby, D M Hansell, R M Du Bois, A G Nicholson.   

Abstract

AIMS: Respiratory bronchiolitis (RB) and desquamative interstitial pneumonia (DIP) are closely associated histological patterns of interstitial pneumonia, although there are no studies on the extent of individual histological parameters. Furthermore, the term smoking related-interstitial lung disease (SR-ILD) has been proposed as a term to encompass patients with both these histological patterns who give a history of smoking, though it is not well defined how this term relates to historical cases of DIP. The aim of this study was to compare histological parameters in cases of DIP and RB and then to review in detail clinical, imaging and histological data for DIP in relation to a history of smoking. METHODS AND
RESULTS: Forty-nine cases were reviewed, 24 with RB and 25 with DIP; five cases of DIP were re-classified as RB on review due to bronchocentricity of the infiltrate. There was a significantly greater extent of interstitial fibrosis (P = 0.02), lymphoid follicles (P < 0.001) and eosinophilic infiltration (P < 0.0001) in patients with DIP compared with RB. In addition, the extents of these three parameters were significantly interrelated. Patients with DIP had a lower incidence of smoking (60%) when compared with patients with RB-ILD (93%) (P < 0.005). Further analysis of smokers versus never-smokers with DIP showed no difference in histological parameters, extent of haemosiderin deposition or the number of CD1a+ macrophages between the two groups, nor were there any differences in clinical data to suggest other aetiologies. Follow-up high-resolution computed tomography data from patients with DIP suggested that a pattern of fibrotic non-specific interstitial pneumonia (NSIP) may develop in the long term in both smokers and never-smokers.
CONCLUSION: There are significant differences in the extent of interstitial fibrosis, lymphoid follicles and eosinophilic infiltration between DIP and RB, as well as a much lower incidence of smoking in patients with DIP. Whether the lower reported incidence of smoking in DIP reflects referral bias or conservatism in giving a history of smoking remains uncertain, as neither histological parameters nor clinical data indicate a difference between smokers and never-smokers with DIP. Nevertheless, some cases of DIP are likely to remain idiopathic and unrelated to RB, though still have a good prognosis. Furthermore, they may evolve into a pattern resembling fibrotic NSIP. Therefore, whilst SR-ILD is appropriate in the correct clinical setting, the distinction between the histological patterns of RB and DIP remains appropriate. Copyright 2004 Blackwell Publishing Limited

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330806     DOI: 10.1111/j.1365-2559.2004.01921.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

1.  [Interstitial lung diseases (ILD) in smokers: spectrum in high resolution computed tomography (HRCT)].

Authors:  K Marten-Engelke
Journal:  Radiologe       Date:  2013-09       Impact factor: 0.635

2.  [A 47-year-old patient with longstanding nicotine abuse, increasing dyspnea on exertion and lower and peripheral lung predominant ground-glass opacities].

Authors:  P Heiss; C Kundel; C Schulz; S Feuerbach; O W Hamer
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

3.  Diffuse interstitial lung disease: overlaps and uncertainties.

Authors:  Simon L F Walsh; David M Hansell
Journal:  Eur Radiol       Date:  2010-03-04       Impact factor: 5.315

Review 4.  Classification and natural history of the idiopathic interstitial pneumonias.

Authors:  Dong Soon Kim; Harold R Collard; Talmadge E King
Journal:  Proc Am Thorac Soc       Date:  2006-06

5.  Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Authors:  Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

6.  Pulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis?

Authors:  Anastasia Oikonomou; Paraskevi Mintzopoulou; Argyris Tzouvelekis; Petros Zezos; George Zacharis; Anastasios Koutsopoulos; Demosthenes Bouros; Panos Prassopoulos
Journal:  World J Radiol       Date:  2015-09-28

7.  [Current classification of interstitial pulmonary diseases].

Authors:  J Vogel-Claussen; A Prasse
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

8.  CT findings associated with survival in chronic hypersensitivity pneumonitis.

Authors:  Jonathan H Chung; Steven M Montner; Ayodeji Adegunsoye; Justin M Oldham; Aliya N Husain; Rekha Vij; Imre Noth; Mary E Strek
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

Review 9.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.

Authors:  Athol U Wells; Andrew G Nicholson; David M Hansell
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.